NewsRx

Search our medical news database

Parainfluenza

Immune Reponse Seen with Intranasal Virus Vaccine

Published in Vaccine Weekly, April 12th, 1999

Another needleless route for immunization is being explored for childhood respiratory illnesses.

The second most common cause of croup, bronchiolitis, and pneumonia in infants, after respiratory syncytial virus (RSV), is parainfluenza virus type 3 (PIV3). David Greenberg, MD, Children's Hospital of Pittsburgh, Pennsylvania, reported on a clinical study of bovine PIV3 vaccine that is administered by intranasal spray.

In the study, 192 infants were randomized to receive the intranasal vaccine or placebo at ages two, four, six, and 12-15 months. Other regularly scheduled childhood immunizations, such as the diptheria-tetanus-pertussis vaccine, were...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook